{"id":"W3214655201","doi":"10.1101/2021.11.03.21265533","title":"Effect of the Neutralizing SARS-CoV-2 Antibody Sotrovimab in Preventing Progression of COVID-19: A Randomized Clinical Trial","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"William Osler Health System","funders":"Vir Biotechnology; GlaxoSmithKline","keywords":"Medicine; Placebo; Randomized controlled trial; Coronavirus disease 2019 (COVID-19); Clinical endpoint; Internal medicine; Clinical trial; Severity of illness; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Disease; Infectious disease (medical specialty); Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00261303,0.00151324,0.002910778,0.0004534848,0.0005198125,0.001251374,0.0008989696,0.002541953,0.007371001],"category_scores_gemma":[0.002643849,0.0006295986,0.002619286,0.0004554535,0.0012563,0.001004341,0.0003978486,0.002495878,0.000717815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006149875,"about_ca_system_score_gemma":0.001173507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009217059,"about_ca_topic_score_gemma":0.001325265,"domain_scores_codex":[0.9989183,0.0006651758,0.00008168077,0.0001414036,0.0000697022,0.0001237362],"domain_scores_gemma":[0.9985689,0.0005515415,0.0003387037,0.00009283306,0.00009677186,0.0003512777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9897996,0.002771161,0.0002600254,0.0003770636,0.0005731345,0.00001734875,0.00001853998,0.0001330763,0.0008062184,0.00006429191,0.0003277852,0.004851747],"study_design_scores_gemma":[0.9785364,0.02016505,0.000484046,0.0000290954,0.0002774086,0.00000733872,0.000007584186,0.0001736784,0.00008966204,0.00006468617,0.0001596988,0.000005236476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9735715,0.009464617,0.0008907929,0.001629342,0.001496901,0.008396913,0.001271717,0.000137086,0.003141038],"genre_scores_gemma":[0.9801744,0.004151057,0.001637345,0.001898481,0.0009408344,0.00808969,0.0008645682,0.00002010515,0.002223446],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007371001,"threshold_uncertainty_score":0.0246585,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08906960352248401,"score_gpt":0.4873188389306667,"score_spread":0.3982492354081827,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}